Danaher Diagnostics — Total Assets increased by 0.8% to $14.65B in Q3 2025 compared to the prior quarter.
An increase typically signals capital investment or acquisition activity to expand diagnostic capabilities, while a decrease may indicate asset divestiture, impairment, or depreciation outpacing new investment.
This metric represents the total carrying value of assets specifically allocated to the diagnostics business segment. It...
Comparable to segment-specific asset bases reported by diversified life science and medical technology peers, often analyzed alongside segment revenue to determine asset turnover efficiency.
dhr_segment_diagnostics_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $15.05B | $14.72B | $14.55B | $14.20B | $14.29B | $14.54B | $14.65B |
| QoQ Change | — | -2.2% | -1.2% | -2.4% | +0.6% | +1.7% | +0.8% |
| YoY Change | — | -2.2% | -1.2% | -2.4% | — | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.